Form 13-F position report

HCA HEALTHCARE INC COM STK

Reported by LOEWS CORP

HCA CUSIP 40412C101 Manager CIK 0000060086

Reported 57,500 shares, down 35,000 (37.8%) from the prior quarter.

Reported value -28.5%; share count -37.8% vs. the prior quarter.

Reduced
% of reported 13F value 0.18% This manager · Q2 2023
Shares 57,500 Quarter-end amount reported
Reported value $17,450,100 Fair value at quarter end
Consecutive quarters held 5 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-06-30 20167000
2022-09-30 22974000
2022-12-31 23996000
2023-03-31 24390400
2023-06-30 17450100
2023-09-30 14143850
2023-12-31 17594200
2024-03-31 17510325
2024-06-30 8032000
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

10 quarters
Quarterly reported position history for HCA HEALTHCARE INC COM STK held by LOEWS CORP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -25,000 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 25,000 -27,500 (-52.4%) 0.07% $8,032,000 2024-07-29
Q1 2024 Reduced 52,500 -12,500 (-19.2%) 0.15% $17,510,325 2024-05-06
Q4 2023 Added 65,000 +7,500 (13.0%) 0.16% $17,594,200 2024-02-09
Q3 2023 Unchanged 57,500 0 (0.0%) 0.14% $14,143,850 2023-11-13
Q2 2023 Reduced 57,500 -35,000 (-37.8%) 0.18% $17,450,100 2023-08-09
Q1 2023 Reduced 92,500 -7,500 (-7.5%) 0.25% $24,390,400 2023-05-11
Q4 2022 Reduced 100,000 -25,000 (-20.0%) 0.22% $23,996,000 2023-02-10
Q3 2022 Added 125,000 +5,000 (4.2%) 0.24% $22,974,000 2022-11-10
Q2 2022 New 120,000 +120,000 (0.0%) 0.18% $20,167,000 2022-08-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1083 managers reported HCA HEALTHCARE INC COM STK for Q2 2023.

Managers reporting HCA HEALTHCARE INC COM STK in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 17,482,258 -406,436 0.13% $5,305,515,658 41 qtrs
BlackRock Inc Added 14,898,753 +213,172 0.12% $4,521,473,573 41 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 10,960,076 -1,935,280 0.63% $3,326,163,864 41 qtrs
Sanders Capital LLC Added 10,939,667 +354,323 6.94% $3,319,970,141 13 qtrs
STATE STREET CORPORATION Added 8,975,423 +149,750 0.14% $2,723,861,372 41 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 5,746,410 -2,227,614 0.24% $1,743,922,000 41 qtrs
Bank of America Corporation Added 5,080,819 +1,097,675 0.16% $1,541,927,011 41 qtrs
First Eagle Investment Management LLC Reduced 4,556,365 -32,653 3.54% $1,382,765,650 21 qtrs
JPMorgan Chase & Co Reduced 4,456,271 -50,658 0.15% $1,352,389,116 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 3,800,828 -12,133 0.14% $1,149,975,750 41 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 09, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
57,500
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.